These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16510768)

  • 1. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.
    Schifitto G; Peterson DR; Zhong J; Ni H; Cruttenden K; Gaugh M; Gendelman HE; Boska M; Gelbard H
    Neurology; 2006 Mar; 66(6):919-21. PubMed ID: 16510768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
    Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
    AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
    Schifitto G; Zhang J; Evans SR; Sacktor N; Simpson D; Millar LL; Hung VL; Miller EN; Smith E; Ellis RJ; Valcour V; Singer E; Marra CM; Kolson D; Weihe J; Remmel R; Katzenstein D; Clifford DB;
    Neurology; 2007 Sep; 69(13):1314-21. PubMed ID: 17652642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium improves HIV-associated neurocognitive impairment.
    Letendre SL; Woods SP; Ellis RJ; Atkinson JH; Masliah E; van den Brande G; Durelle J; Grant I; Everall I;
    AIDS; 2006 Sep; 20(14):1885-8. PubMed ID: 16954730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
    Gulick RM; Su Z; Flexner C; Hughes MD; Skolnik PR; Wilkin TJ; Gross R; Krambrink A; Coakley E; Greaves WL; Zolopa A; Reichman R; Godfrey C; Hirsch M; Kuritzkes DR;
    J Infect Dis; 2007 Jul; 196(2):304-12. PubMed ID: 17570119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 infection and cognitive impairment in the cART era: a review.
    Schouten J; Cinque P; Gisslen M; Reiss P; Portegies P
    AIDS; 2011 Mar; 25(5):561-75. PubMed ID: 21160410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy.
    Bakanda C; Birungi J; Mwesigwa R; Ford N; Cooper CL; Au-Yeung C; Chan K; Nachega JB; Wood E; Hogg RS; Dybul M; Mills EJ
    AIDS; 2011 Mar; 25(5):701-5. PubMed ID: 21160412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No change to HIV-1 latency with valproate therapy.
    Steel A; Clark S; Teo I; Shaunak S; Nelson M; Gazzard B; Kelleher P
    AIDS; 2006 Aug; 20(12):1681-2. PubMed ID: 16868456
    [No Abstract]   [Full Text] [Related]  

  • 10. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of glutamate levels in HIV-infected subjects treated with acetylcarnitine.
    Famularo G; Moretti S; Alesse E; Trinchieri V; Angelucci A; Santini G; Cifone G; De Simone C
    J NeuroAIDS; 1999; 2(2):65-73. PubMed ID: 16873195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.
    Sagot-Lerolle N; Lamine A; Chaix ML; Boufassa F; Aboulker JP; Costagliola D; Goujard C; Pallier C; Delfraissy JF; Lambotte O;
    AIDS; 2008 Jun; 22(10):1125-9. PubMed ID: 18525257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).
    Wagner GJ; Kanouse DE; Golinelli D; Miller LG; Daar ES; Witt MD; Diamond C; Tilles JG; Kemper CA; Larsen R; Goicoechea M; Haubrich RH
    AIDS; 2006 Jun; 20(9):1295-302. PubMed ID: 16816559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.
    Fox J; Dustan S; McClure M; Weber J; Fidler S
    HIV Med; 2006 Oct; 7(7):477-83. PubMed ID: 16925735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
    Launay O; Duval X; Dalban C; Descamps D; Peytavin G; Certain A; Mouajjah S; Ralaimazava P; Verdon R; Costagliola D; Clavel F;
    Antivir Ther; 2006; 11(7):889-99. PubMed ID: 17302251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV agents. Can valproic acid help flush HIV from hiding?
    TreatmentUpdate; 2005; 17(6):4-5. PubMed ID: 17228475
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men.
    Jong E; van Gorp EC; Mulder JW; Tol A; Smits PH
    Int J STD AIDS; 2009 Apr; 20(4):262-4. PubMed ID: 19304972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.